Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.

Journal of surgical oncology - 1 Nov 2017

Handa Tadashi, Katayama Ayaka, Yokobori Takehiko, Yamane Arito, Horiguchi Jun, Kawabata-Iwakawa Reika, Rokudai Susumu, Bao Pinjie, Gombodorj Navchaa, Altan Bolag, Kaira Kyoichi, Asao Takayuki, Kuwano Hiroyuki, Nishiyama Masahiko, Oyama Tetsunari

Abstract excerpt

BACKGROUND AND OBJECTIVES: The Caspase14 (CASP14) was reported that the low expression of CASP14 in ovarian cancer and colon cancer was associated with cancer progression, on the other hand, that the CASP14 expression in breast cancer was higher than that of non-cancerous tissues. The purpose of this study is to determine the clinical significance of CASP14 in breast cancer. METHODS: We performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caspases
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Immunohistochemistry

Share to MCF-7 Cells

Share to Neoplastic Stem Cells

Share to Phenotype

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 28570747
DOI: 10.1002/jso.24705

Genes

CASP14
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.PMID 28570747Read ↗

CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancerSemantic proximity Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.Semantic proximity Read ↗

Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development.Semantic proximity Read ↗

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of AnnexinsSemantic proximity Read ↗

CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.Semantic proximity Read ↗

Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell linesSemantic proximity Read ↗

Aberrant expression of CD14 in breast tumor cells is associated with poor outcomeSemantic proximity Read ↗

Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological typesSemantic proximity Read ↗

Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.Semantic proximity Read ↗

Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular markerSemantic proximity Read ↗

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.